{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-342316","form_type":"8-K","ticker":"BLSM","cik":"0001839970","company_name":"BlossomHill Therapeutics, Inc.","filed_at":"2026-08-10T20:01:18+00:00","discovered_at":"2026-08-10T20:03:11.445329+00:00","generated_at":"2026-08-10T20:03:35.245795+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BlossomHill Therapeutics completes IPO of 9.375M shares at $16.00, gross proceeds ~$150M","bullets":["IPO closed Aug 10, 2026; 9,375,000 shares sold at $16.00 per share.","Gross proceeds approximately $150.0M before underwriting discounts and expenses.","Amended and restated certificate of incorporation and bylaws effective Aug 10, 2026.","Stock trades on Nasdaq Global Select Market under ticker BLSM."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-342316","json":"https://secwatch.observer/filing/0001193125-26-342316.json","markdown":"https://secwatch.observer/filing/0001193125-26-342316.md","text":"https://secwatch.observer/filing/0001193125-26-342316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839970/000119312526342316/0001193125-26-342316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839970/000119312526342316/d138762d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:03:35.245795+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}